Location: Boston, MA
CIK: 0001583977 · Show all filings
Period: Q4 2017 (← Previous) (Next →)
Filing Date: Feb 14, 2018
Total Value: $955M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ANAB | ANAPTYSBIO INC | 1,251,485 | $126M | 13.2% | $34.01 | +116.4% | COM | 032724106 |
| — | NEKTAR THERAPEUTICS | 1,997,700 | $119M | 12.5% | $59.72 | — | COM | 640268108 |
| APLS | APELLIS PHARMACEUTICALS INC | 3,768,757 | $81.78M | 8.6% | $14.72 | 0.0% | COM | 03753U106 |
| — | NEKTAR THERAPEUTICS | 750,000 | $44.79M | 4.7% | $59.72 | — | Call | 640268108 |
| OMER | OMEROS CORP | 1,750,000 | $34M | 3.6% | $17.26 | +8.6% | Call | 682143102 |
| — | BLUEPRINT MEDICINES CORP | 450,000 | $33.94M | 3.6% | $67.43 | — | COM | 09627Y109 |
| — | MYOKARDIA INC | 800,000 | $33.68M | 3.5% | $17.38 | — | COM | 62857M105 |
| — | DICERNA PHARMACEUTICALS INC | 3,656,669 | $33.02M | 3.5% | $9.03 | — | COM | 253031108 |
| IFRX | INFLARX NV | 1,438,207 | $30.13M | 3.2% | $17.97 | 0.0% | COM | N44821101 |
| — | JUNO THERAPEUTICS INC | 550,000 | $25.14M | 2.6% | $30.37 | — | COM | 48205A109 |
| TBPH | THERAVANCE BIOPHARMA INC | 900,000 | $25.1M | 2.6% | $23.62 | +25.3% | COM | G8807B106 |
| — | MIRATI THERAPEUTICS INC | 1,231,522 | $22.48M | 2.4% | $12.93 | — | COM | 60468T105 |
| — | QUOTIENT LTD | 4,488,121 | $22.22M | 2.3% | $9.14 | — | SHS | G73268107 |
| — | AVEXIS INC | 200,000 | $22.13M | 2.3% | $110.67 | — | COM | 05366U100 |
| — | PROTEOSTASIS THERAPEUTICS IN | 3,300,000 | $19.24M | 2.0% | $12.20 | — | COM | 74373B109 |
| ARGX | ARGENX SE | 290,000 | $18.31M | 1.9% | $63.14 | — | SPONSORED ADR | 04016X101 |
| QTRX | QUANTERIX CORP | 847,789 | $18.2M | 1.9% | $19.52 | 0.0% | COM | 74766Q101 |
| — | G1 THERAPEUTICS INC | 897,505 | $17.81M | 1.9% | $20.91 | — | COM | 3621LQ109 |
| OMER | OMEROS CORP | 875,000 | $17M | 1.8% | $17.26 | +8.6% | COM | 682143102 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 200,000 | $15.52M | 1.6% | $15.30 | +345.9% | COM | 64125C109 |
| — | BLUEBIRD BIO INC | 80,000 | $14.25M | 1.5% | $105.05 | — | COM | 09609G100 |
| ANAB | ANAPTYSBIO INC | 135,000 | $13.6M | 1.4% | $34.01 | +116.4% | Call | 032724106 |
| — | CLEARSIDE BIOMEDICAL INC | 1,940,880 | $13.59M | 1.4% | $7.30 | — | COM | 185063104 |
| ACRS | ACLARIS THERAPEUTICS INC | 550,000 | $13.56M | 1.4% | $19.94 | +22.1% | COM | 00461U105 |
| ASND | ASCENDIS PHARMA A S | 300,000 | $12.02M | 1.3% | $40.06 | — | SPONSORED ADR | 04351P101 |
| — | AUDENTES THERAPEUTICS INC | 337,876 | $10.56M | 1.1% | $18.38 | — | COM | 05070R104 |
| — | ABEONA THERAPEUTICS INC | 575,000 | $9.114M | 1.0% | $8.20 | — | COM | 00289Y107 |
| — | ARRAY BIOPHARMA INC | 700,000 | $8.96M | 0.9% | $6.75 | — | COM | 04269X105 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 400,000 | $8.32M | 0.9% | $13.67 | +29.8% | COM | 74366E102 |
| — | BIOHAVEN PHARMACTL HLDG CO L | 297,803 | $8.035M | 0.8% | $26.98 | — | COM | G11196105 |
| WVE | WAVE LIFE SCIENCES LTD | 202,079 | $7.093M | 0.7% | $17.46 | +67.0% | SHS | Y95308105 |
| ZLAB | ZAI LAB LTD | 333,166 | $7.073M | 0.7% | $27.00 | — | ADR | 98887Q104 |
| SGMO | SANGAMO THERAPEUTICS INC | 400,000 | $6.56M | 0.7% | $6.37 | +133.4% | COM | 800677106 |
| — | GEMPHIRE THERAPEUTICS INC | 800,000 | $6.36M | 0.7% | $10.90 | — | COM | 36870A108 |
| — | REATA PHARMACEUTICALS INC | 200,000 | $5.664M | 0.6% | $31.10 | — | CL A | 75615P103 |
| COLL | COLLEGIUM PHARMACEUTICAL INC | 300,000 | $5.538M | 0.6% | $17.28 | -17.1% | COM | 19459J104 |
| — | MERSANA THERAPEUTICS INC | 295,548 | $4.856M | 0.5% | $16.39 | — | COM | 59045L106 |
| — | JOUNCE THERAPEUTICS INC | 367,223 | $4.682M | 0.5% | $21.80 | — | COM | 481116101 |
| — | TRILLIUM THERAPEUTICS INC | 600,000 | $4.38M | 0.5% | $4.40 | — | COM NEW | 89620X506 |
| — | INTEC PHARMA LTD JERUSALEM | 809,804 | $4.17M | 0.4% | $5.59 | — | SHS | M53644106 |
| — | MARINUS PHARMACEUTICALS INC | 500,000 | $4.08M | 0.4% | $8.16 | — | COM | 56854Q101 |
| ARDX | ARDELYX INC | 572,738 | $3.78M | 0.4% | $15.57 | -61.9% | COM | 039697107 |
| — | MINERVA NEUROSCIENCES INC | 607,903 | $3.678M | 0.4% | $7.26 | — | COM | 603380106 |
| HRTX | HERON THERAPEUTICS INC | 200,000 | $3.62M | 0.4% | $15.72 | +3.7% | COM | 427746102 |
| — | CONTRAFECT CORP | 3,550,000 | $3.586M | 0.4% | $2.80 | — | COM | 212326102 |
| — | ACCELERON PHARMA INC | 75,000 | $3.183M | 0.3% | $32.04 | — | COM | 00434H108 |
| — | SYROS PHARMACEUTICALS INC | 296,296 | $2.883M | 0.3% | $16.09 | — | COM | 87184Q107 |
| OVID | OVID THERAPEUTICS INC | 223,972 | $2.211M | 0.2% | $13.06 | -29.7% | COM | 690469101 |
| — | ONCOBIOLOGICS INC | 30,536 | $40,000 | 0.0% | $3.28 | — | COM | 68235M105 |
| — | ONCOBIOLOGICS INC | 416,666 | $13,000 | 0.0% | $0.46 | — | *W EXP 02/18/201 | 68235M113 |
| — | ONCOBIOLOGICS INC | 416,666 | $9,000 | 0.0% | $0.45 | — | *W EXP 05/18/201 | 68235M121 |
| — | CELLECTAR BIOSCIENCES INC | 52,999 | $5,000 | 0.0% | $0.55 | — | *W EXP 08/20/201 | 15117F120 |